Home▸Andropause Testosterone Therapy▸Age-Related Testosterone Decline Natural Curve Simulator

👨 Age-Related Testosterone Decline Natural Curve Simulator

This simulation illustrates the natural decline of testosterone levels over age. It provides a detailed chart showing how testosterone levels typically change with advancing age in men and women, helping to understand normal physiological variations.

Andropause Testosterone Therapy2DModerate60 FPS

Peak Testosterone in Early Adulthood

Testosterone reaches its lifetime peak in the twenties.

~650 ng/dL: Peak level (typical adult male peak)
20–30: Peak age window (years)
~10 yrs: Plateau duration (before decline begins)
Downward: Post-peak trend (gradual, not sudden)

What defines the peak years

Placeholder: brief note on hormonal peak physiology.

Gradual ~1% Annual Decline After 30

Levels decrease slowly, near one percent per year on average.

~1%: Annual decline (per year after 30)
~20%: By age 50 (cumulative decline)
~40%: By age 70 (cumulative decline)
Exponential-like: Curve shape (compounding decline)

Why decline is gradual, not abrupt

Placeholder: brief note on gradual endocrine aging.

Distinguishing Normal Aging From Pathology

Some decline is normal; sharp drops may signal disease.

300 ng/dL: Normal floor (lower reference bound)
<231 ng/dL: Low threshold (clinical low range)
Pathological: Hypogonadism (distinct from aging)
Labs + symptoms: Diagnosis basis (combined assessment)

How clinicians separate the two

Placeholder: brief note on differential diagnosis approach.

Individual Variability in Decline Rate

Decline speed differs a lot between individual men.

0.5x–2x: Rate range (individual modifier range)
Genetics, health: Key factors (lifestyle, body composition)
Faster decline: Obesity effect (accelerates drop)
Slower decline: Fitness effect (may preserve levels)

Sources of individual variation

Placeholder: brief note on variability drivers.

When Decline Becomes Clinically Significant

Below a threshold, symptoms and treatment become relevant.

~300 ng/dL: Symptom threshold (below this, symptoms common)
<231 ng/dL: Treatment considered (with symptoms present)
Fatigue, low libido: Common symptoms (mood changes)
Yes: Evaluation needed (below clinical threshold)

What clinical significance means here

Placeholder: brief note on when to seek evaluation.

Placeholder: short callout on seeking clinical guidance.

⚙ Under the hood

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install